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&man platelets were disrupted using nitrogen cavitation and fractionated on sucrose density gradients to permit isolation of cz-granules, the major 
secretory granule of platelets. Membrane proteins prepared from intact &-granules by alkali extraction were seperated by SDS-polyacrylamide g l 
electrophoresis, transferred to nitrocellulose and the blot probed for the presence of GTP-binding proteins using [o~-~~P]GTP. Two low molecular 
mass GTP-binding proteins with molecular mass of 27 and 24 kDa, respectively, were identified on the a-granule membrane. In contrast o the 
27-kDa protein which was present in significant amounts in the plasma membrane-enriched fraction, the 24.kDa protein showed a preferential 
association with the a-granule membrane. On immunoblotting with specific antiserum. the 24.kDa GTP-binding protein was found to bc distinct 
from rab3A. TO the best of our knowledge, the present report represents the first identification of low molecular mass GTP-binding proteins 
associated with a platelet secretory granule. 
G,-protein; GTP-binding protein; Platelet: E-Granule 
1. HNTRQDUCTION 
More than thirty mammalian GTP-binding proteins 
with molecular mass between 17-27 kDa have been 
identified in the past 5 years [2-4]. A specific function 
for any of the low molecular mass GTP-binding pro- 
teins remains to be elucidated. However, based on func- 
tional studies in temperature-sensitive yeast mutants [5- 
71 as well as subcellular localization studies in mamma- 
lian systems [H-12], there is reason to anticipate a role 
for some of these low molecular mass GTP-binding 
proteins in mediating the known GTP dependency of 
several intracellular membrane trafficking processes 
[ 13-161, including secretion by exocytosis [6,12,17]. The 
rab subfamily of rus-like GTP-binding proteins has re- 
ceived specific attention in this regard [18]. 
The subject of low molecular mass GTP-binding pro- 
teins in platelets has been recently reviewed [ 191. While 
at least 15 such proteins have been identified in the 
platelet o date, little is known about their subcellular 
localization and even less about their possible function. 
PlateIcts contain three recognized populations of se- 
cretory granules, namely, d-granules, dense granules 
and lysosomes, with or-granules being the most a’~!n- 
dant [20]. The aim of the present work was to determine 
AbhrevirrlioW GTPyS, guanosinc 5’.[y-thioltriphosphatc; G,,-pro- 
tcins, 23-27.kDiI proteins dctcctcd by binding of&““P]GTP to nitro- 
CCIIU~OSC blots [I]. 
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the presence of low molecular mass GTP-binding pro- 
teins in association with the platelet a-granule. We 
report the detection of a 24.kDa G-l-P-binding protein, 
termed C,24, that demonstrates a preferential associa- 
tion with the a-granule membrane but is not recognized 
by antiserum raised against he rab3A protein. Possible 
identity with a previously reported platelet 24.kDa 
GTP-binding protein, capable of interaction with ,the 
GDP dissociation inhibitor protein for brain smq p25A 
[21], is discussed. 
2. EXPERIMENTAL 
2.1, Mnlerids 
[CZ-“‘P]GTP was from ICN Radiocheniicals(Irvine. CA, USA). Tris, 
ATP (disodium salt) and chymotrypsin were obtained from Boehrin- 
gcr Mannhcim Canada Ltd, (Dorval, Que., Canada). Bovine serum 
albumin, Z-deoxy-D-glucose, EDTA (sodium salt), Triton X-100, cy- 
tochronle c type III, protein standard solution, I)-nitrophcnyl-2-acc- 
tamido-2.deoxy-P-D-glucopyranosidc and low M,. protein standards 
for SDS-polyacrylamidc gels were obtained from Sigma Chemical Co. 
(St, Louis. MO, USA). Rotenonc and phcnylmethylsulfony1 fluoride 
(PMSF) wcrc from Aldrich (Milwaukee, WI, USA). Nitroccllulosc 
mcnibrenc (0.2 pm port) and prcstained protein markers for USC on 
SDS-polyacrylamidc gels wcrc obtained front Bio-Rad Laboratories 
(Mississauga, Ont,, Canada). nadioinlnlulloilssay kit forp-thrombo- 
globulin was from Amcrshanl (Oakvillc, Ont,. Canada). ““I-IPbcllcd 
Concanavalin A was purchnacd from New Englsnd Nuclear (Mon. 
trcill. Quc.. Canada). All othrr rcagcnts used wcrc of analytical gredc. 
TW hundred ml of blood Was rollcctcd from healthy volunteer 
donors into 0.15 valumcs of ACD anticoagulant and ccntrifugcd at 
28OxJr for 15 min at room tcmpcralurc to product pletrlct.rich plasma 
(PBP). Thr: P#P wus udjustcd to 5 mM EDTA and centrifuged ill 
3500~~ for IS mill at 4% to yield a pletclet pcllct. The platelets were 
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washed by resuspension and centrifugation at 17OOxg for 10 min at 
4°C in Ca*‘-fret Tyrode’s solution (137 mM NaCl, 2.7 mM KCI, 12 
mM NaHCO,, 0.42 mM NaH,POd, 5.5 mM glucose, 2 mM MgCl*) 
that also contained 10 mM PIPES (PI-I 6.5), 1 mM EDTA and BSA 
(3.5 mdml). The final platelet pellet was resuspended in 15 ml of this 
same buffer. 
2.3. Platelet sub-fractionation and isolution of u-granules 
Human platelet sub-fractionation was carried out using minor mo- 
difications to a protocol previously used for pig platelet [22]. The 
platelet suspension was adjusted to 5 mM in 2-deoxy-D-glucose and 
20pM rotenone (from 10 mM stock in DMSO) and incubated at 37°C 
for 40 min. Chymotrypsin (0.1 mg/ml) and ATP (final concn. 5 mM) 
were added and the incubation continued for a further 5 min at room 
temperature. Chymotrypsin was neutralized by the addition of a la.rge 
molar excess of PMSF (1 mM) and platelets collected by centrifuga- 
tion at 17OOxg for 10 min at 4OC. The platelets were resuspended in 
a buffer (TRB) containing 10 mM Tris-HCI (pH 7.4), 250 mM sucrose, 
1 mM EDTA and 0.15 mM PMSF. added to a pre-cooled nitrogen 
bomb (Parr Instruments Co., Moline, IL) and disrupted by three 10 
min cycles of nitrogen cavitation at 1200 psi. The resulting homoge- 
nate was centrifuged at IOOOxg for 20 min at 4°C to remove intact or 
incompletely lysed platelets and then re-centrifuged at 32 OOOxg for 
30 min. The pellet obtained was resuspended in 3 ml of ice-cold TRB 
and laycrcd onto a 30 ml discontinuous sucrose gradient (1.2-2.0 M 
sucrose in TRB. 0.2 M steps) and centrifuged at 135 9OOxg for 3 h at 
4°C. Fractions were harvested from the sucrose gradient in l-ml ali- 
quots, pooled according to visible bands (see Fig. I), slowly diluted 
into TRB to minimize granule lysis, and centrifuged at 32 OOOxg for 
30 min. Pelleted fractions were resuspended in TRB for further anal- 
ysis. 
2.4. Preparation qf cr-granule mwtbra~tes 
The pellet corresponding to the c+granule-rich fraction (i.e. fraction 
III = B4 + B5, Fig. 1) was resuspended in 1 ml of 0.1 M NalCOj 
solution, incubated for 15 min at 4°C and centrifuged at 100 OOOXg 
for 30 min. The resulting pellet, designated ‘a-granule membranes’, 
was resuspended in TRB for further analysis. 
2.5. Marker assays 
Rsdiolabelled Concanavalin A was used to identify plasma mem- 
brane during the platelet sub-fractionation [23]. In brief, prior to the 
nitrogen cavitation step, intact platelets (4x log/ml) were incubated for 
5 min at 37’C in TRB containing 210 nCi/ml of ‘ZJI-Iabelled Consa- 
navalin A. At the end of this incubation, the platelets were washed 
twice in ice-cold TRB and collected by centrifugation at 17OOxg for 
10 min at 4°C. The platelets were then resuspended in TRB for nitro- 
gen cavitation and sub-fractionated as described above. lz51 associated 
with the various fractions was determined using an LKB Wallac uni- 
versa1 gamma counter. 
Cytochromc c oxidase was used as a marker for mitochondria [24] 
and N-acetyl glucosaminidase as a marker for lysosomc [as]. /3-throm- 
boglobulin, an cl-granule specific polypeptide [26], was measured using 
a commercially available radioimmunoassay kit. Briefly, fora-throm- 
boglobulin measurement, he subcellular fractions were solubilized in 
1% TritonX-100 (15 min at room temperature),diluted toO.l%Triton 
X-100 wit11 TKB, and further diluted as required with TRB containing 
0.1% Triton X-100 for use in the radioimmunoassay. Human@-throm- 
boglobulin standards were similarily prepared in TRB containing 
0.1% Triton X-100. The RIA procedure described by the manifacturer 
was modified to assay twice the usual number ofsamples by decreasing 
the volumes two-fold. An additional (NH&SOP wash was also in- 
eluded [27]. 
2.6. SDS-pol.vacrylantide gel electroplroresis and blotting of proteins 
For SDS-polyacrylamide gel electrophoresis, one volume of 5X 
concentrated Laemmli’s sample buffer [ZS] was added to four volumes 
of solution containing proteins. The samples were heated at 100°C for 
3 min and analyzed by SDS-polyacrylamide gel electrophoresis using 
13% (w/v) acrylamide in the separating el [28]. The resolved polypep- 
tides were then transferred onto nitrocellulose using the procedure 
described in [29] except that the concentration of SDS used in the 
transfer butTer was 0.05%. 
2.7. Detection of G,-proteins on nitrocellulose blots 
The procedure for the detection of G,-proteins upon incubation of 
nitrocellulose blots with [ol-32P]GTP has been described in detail else- 
where [I]. Bound “P was detected by autoradiography (12-72 h at 
-50°C using a Cronex intensifying screen) and quantitated by coun- 
ting Cerenkov radiation. 
I II ill 2.9. Itwrtunoblotting 
The detection of rnb3A in the various platelet subcellular fractions 
and bovine brain membrane was carried out using antiserum raised 
against the recombinant rab3A protein, The method used for immuno- 
detection has been described previously [30]. 
3. RESULTS 
1.2 1.4 1.6 4.8 23 
SWWse cont. (MI 
Fig. 1, Photograph of a typical sucrose density gradient platclct sub- 
fractionation, Platclcts were isolutcd, subjcctcd to ATP-deplc[ion with 
2.D-dcoxyglucosc and rotcnonc followctl by limited protcolysis with 
chymotrypsin in the prcscare of ATP, as described in section 2. The 
platclcts wcrc disruptccl by nitrogen cavitation and scpar;ttcd on a 30 
ml discontinous sucrose grildicnt (I ,240 M sucrose. in 0,2 M s~cps). 
Thti predicnt w;is collcctcd in I ml frrrctiom aud the b:ulds poelcd into 
three larger fractkms 14s intlic;~tcd (LJII). 
To study a-granules for the presence of low molecular 
mass GTP-binding proteins we sub-fractionated human 
platelets by applying, with minor modifications, a 
method we had previously successfully applied to pig 
platelets [22]. To improve &granule yield, ATP-deplc- 
tion (using 2-deoxy-2.D-glucose and rotenone), and 
limited proteolysis of the intact platelet (using chymo- 
trypsin) were included in the procedure as these two 
steps have been shown to contribute towards greater 
recovery of secretory ranulcs during platclct sub”frac- 
tionation [32]. 
123 
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Platelets, prepared and disrupted as described in sec- 
tion 2, separated on discontinuous sucrose gradients in 
a reproducible pattern comprising 5 distinct bands (Fig. 
1). The top two bands (i.e. Bl, IX?), occurring as a 
closely spaced doublet within the 1.2 M sucrose phase, 
were pooled (see below) and designated as fraction I. 
The third band (i.e. B3), designated as fraction II, for- 
med in the region of the 1.2-l .4 M sucrose interphase. 
ES4 and B5 formed at the 1.4-1.6 M and 1.6-l.R M 
interphases respectively. B5 appeared as a fine aggre- 
gate and cou!d be readily dispersed. B4 and I35 were 
pooled (see below) and designated as fraction III. A 
pellet, presumed to be enriched in dense granules 
[22,32], was observed in most preparations but was not 
recovered due to the small amount of material present. 
A variety of markers were used to characterize the 
platelet subfractions. The tight binding of Concanavalin 
A to the outer aspect of the intact cell was used to follow 
plasma membrane during the sub-fractionation proce- 
dure [23]. In our preparation, maximal ‘2SI-labelled 
Concanavalin A binding (cpm/mg protein) was found 
in fraction I (comprising bands 1 and 2) (Fig. 2), con- 
sistent with previous observations that this low density 
fraction is enriched in plasma membrane [22,32]. Rela- 
tive enrichment over lysate was 2.4-fold in a single ex- 
periment in which pelleted fractions I-III were simulta- 
neously prepared for other marker studies. Identical 
results in terms of plasma membrane localization were 
Enrichment 1.7 1.4 1.6 1.8 46 03 
Ratis: t&P4 (0.11 !O.l) (0.11 b3.1) Px3) io.11 
Fig. 3. Detection of G,-proteins in platelet subcellular fractions. Pro- 
teins (25 pg) in the various subcellular fractions (lane a, lysate: lane 
b, solution applied to gradient; lane c, fraction I; lane d, fraction II; 
lane e. fraction III; lane f, c+granule membrane; lnnc g, c&granule 
supematant) wcrc clectrophoresed and blotted onto nitrocellulose. To 
detect G,-proteins the blot was incubated with [a-“P]GTP and an 
autoradiogram developed. The enrichment ratio for G,24 was calcul- 
ated by counting the “‘Passociated with this band in various fractions. 
The enrichment value for the lysate was taken as I. Values indicated 
represent the mean enrichment + SEM (given in parentheses) for 4 
independent experiments. 
obtained when 0.6 ml fractions collected from the 30 ml 
density gradient were individually analyzed for 
[‘251]Concanavalin A and protein content. Using this 
approach the average enrichment calculated from the 
individual gradient fractions comprising fraction I was 
somewhat greater (3.7-fold), presumably reflecting the 
absence of the wash step which is included when pelleted 
fractions are prepared from the pooled sucrose gradient 
fractions. N-acetyl glucosaminidase, a marker for lyso- 
somes [25], was found in all three fractions but was 
maximally enriched in fraction II (4.22 I- 0.2-fold, mean 
-I-SEM, n=3) (Fig. 2). P-thromboglobulin, a secretory 
protein marker localized to the a-granules [26], was 
detectable in all three fractions but was maximally en- 
riched in fraction III (4.9 + 0.4%fold, mean -1- §EM, 
r1=3) (Fig. 2). B4 and B5 showed comparable enrich- 
ment in this marker (4.4- and 4.2fold, respectively in a 
separate single experiment) and hence were routinely 
pooled as fraction III. The activity of the mitochondrial 
marker enzyme, cytochrome c oxidase, was detectable 
in the material applied to the gradient (lo,1 -C l&9), 
fraction I (20.48 + 6.6) and fraction II (41.25, J- 10.7) 
(@no1 productlmg/min, mean fSEM, n=3-4) but not in 
fraction III or in whole platelet lysate (using 50-75 ,ug 
total protein per assay), This is consistent with the ex- 
pected localization on sucrose density gradients of mi- 
tochondria from both pig [22] and human [32,33] pla- 
telets, 
Electron microscopy was used to further characterize 
fraction III, This fraction consisted of morphologically 
pure a-granules, recognizable by their characteristic 
shapes und uniformly dense core, with very littlc cvi- 
dencc of contamination by other organcllcs. Treatment 
of intact granules with 0.1 M NaQ.& produced mem- 
brane vesicles largely devoid of their electron dense con- 
tcr1ts (diltn rlot shown). 
The presence of GTP-binding proteins in the various 
Fraction 
Fig. 2. Distribution of’subccllufor morkcrs in platclct fractions. Plasma 
mcmbranc was lacolizcd by followin~[‘~~I]Concanovolin A oftcr incu- 
bation of inloct plot&tS with the radiolobcllcd tcctin (a), &‘-acctyl 
ylucosominidosc (@) and B-thronrboglohulin (RI) wcrc used as markers 
for lysoaamca ond CZ-gl%llUlC5 rcspcctivcly, Specific sctivitics (units per 
mg protein) were colculotcd ror coch fraction and ore exprcsscd rclo- 
tivc to ~irc specific activity mcasurcd in the whale platelet lysorc. 
Rcsultn arc from 3 indcpcndent cxperitncntr (111cn1~ L%IM) cxccpt for 
tlic [‘:~I)Concoi~ovalif~ A prolilc which il: from o kinjllc cxpcrimcnt in 
which frnctians were praccascd in porellcl f’or tlrc nthcr morkcrs, 
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Volume 291, number 1 FEBS LETTERS October 1991 
Fig. 4. lmmunodetection of rab3A in platelet subcellular fractions and 
bovine brain membrane. Proteins (SOpg) in the various platelet subcel- 
Mar fractions (lane a. lysate; lane b, solution applied to gradient: lane 
c, fraction I; lane d, fraction II; lane e. fraction III; lane f. a-granule 
membrane: lane g, a-granule supernatant). recombinant rob3A (lane 
h, 0.5 pg) and whole bovine brain membrane (lane i, 50 ,ug) were 
electrophoresed and blotted onto nitrocellulose. The blot was then 
incubated with antiserum against r~b3A (I:250 dilution) and devel- 
oped using [“SI]protein A as described in section 2. 
platelet subcellular fractions was assessed using [a- 
“PJGTP binding on nitrocellulose blots containing po- 
lypeptides separated by SDS-polyacrylamide gel elec- 
trophoresis. This procedure has been used previously 
for the dletection of GTP-binding proteins (G,-proteins) 
in platelets and other cells [ 11. Two major GTP-binding 
proteins., G,,27 and G,,24, were detected in the various 
platelet subcellular fractions (Fig. 3). The binding of 
[BI-“~P]GTP to G,,-proteins was not affected by the addi- 
tion to the incubation medium of a lOOO-fold excess of 
ATP or GMP but was completely abolished by the ad- 
dition of GTP or GTPyS (results not shown). G,,27 was 
found to be present in all the fractions tested, with the 
plasma membrane-rich fraction I and the a-granule 
membrane fraction showing the greatest degree of en- 
richment (2.4- to 2.8.fold over lysate). However, the 
G,,24 protein was found to be maximally enriched (4% 
foId over Iysate) in the cl-granule membrane fraction 
and only minimally enriched (1.4- to 1%fold over ly- 
sate) in the other subcellular fractions (Fig. 3). The 
platelet cytosol has been previously shown to contain 
only trace amounts of this protein [l]. Furthermore, the 
G,,24 protein could not be recognized in the a-granule 
membranes by Western blotting using an antiserum prc- 
pared against the recombinant 1~t63A protein under 
conditions where the ruB3A protein in whole bovine 
brain membrane and the recombinant ruh3A protein 
were recognized by this antiserum (Fig. 4). 
4. DISCUSSION 
rah3A, a GTP-binding protein which has an apparent 
molecular mass of 25 kDa, is associated with synaptic 
vesicles [9] and chromaffin cell secretory granules [lo]. 
It has been speculated that the rab3A protein may be 
associated with secretory granules from other tissues 
[lo]. The present results demonstrate that the platelet 
a-granule membrane contains a 24 kDa GTP-binding 
protein (G,,24) which is not recognized by a polyclonal 
antiserum to ~763A (Fig. 4). Further dissimilarity is 
underscored by the fact that, whereas mb3A is present 
in substantial amounts in cytoplasm [9,10], G,24 is 
present only in trace amounts in platelet cytosol /lJ. 
It cannot be concluded, however, that G,24 is un- 
related to ~r63A. Fujioka et al. have previously isolated 
a 24-kDa GTP-binding protein (designated 24KG) 
from whole platelet membranes [21]. The 24KG protein 
is of special interest in the present context because: (i) 
it binds [B-~‘P]GTP after transfer to nitrocellulose, (ii) 
it is capable of interacting with the GDP dissociation 
inhibitor (GDI) for brain srl~q p25A (= rab3A) in a 
manner which mimics sr?fq p25A, (iii) platelet cytosol 
contains a GDI, immunologically indistinguishable 
from the bovine brain “nq p25A GDI, which dem- 
onstrates activity towards both the platelet 24KG 
protein and snlq p2SA, and (iv) in spite of these simi- 
larities to srrzq p25A, 24KG is not recognized by anti- 
serum against bovine brain srtty p25A on Western blot- 
ting. These authors have speculated that 24KG and its 
associated GDI may be analogous to the s/nqp25A-smq 
p25A GDI system implicated in secretion by exocytosis 
in neurosecretory tissues. Our localization of a 24 kDa 
GTP-binding protein to the membrane of a platelet se- 
cretory granule is therefore significant, raising the possi- 
bility that G,,24 and 24KG may be identical, and com- 
plementing the data of Fujioka et al. which suggest hat 
a 24-kDa GTP-binding protein may play a role in 
platelet secretion. Furthermore, the present data in- 
crease the probability that, in spite of not being re- 
cognized by specific antisera Iigainst rcrh3A, these 24- 
kDa proteins arc related to the ~nb subfamily of GTP- 
binding proteins. 
To the best of our knowledge, this represents the first 
report describing the presence of low molecular mass 
GTP-binding proteins in association with a platelet se- 
cretory granule. Furthermore, we have shown that, 
under our isolation coliditions, one of the two GTP- 
binding proteins dctcctcd is highly enriched in the a~ 
granule membrane fraction (Fig. 3). This GTP-binding 
protein, which WC have designated as G,,24 on the basis 
of its apparent molecular weight on SDS-polyacryla- 
midc gel clectrophoresis. wus capitblc of binding [OZ- 
“‘P]GTP on incubation of nitrocellulose blots contain- 
7-hc signilicance of ttic association of low molecular 
mass GTP-binding protein(s) with cxocytotic secretory 
granutcs is not well understood, Howcvcr, it has been 
proposed that these proteins may rclatc to the function- 
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ing proteins separated by SDS-polyacrylamide gel 
electrophoresis. Lesser amounts of this protein could be 
detected in fractions I and II. The relative quantities of 
G,24 detected in fractions I and II (Fig. 3) cannot be 
accounted for solely by contamination of these fractions 
with intact a-granules (Fig. 2) but could, nonetheless, 
be due to the presence of membranes derived from of- 
granules disrupted during the sub-fractionation proce- 
dure. Alternatively, it is possible that while G,24 is 
clearly preferentially associated with the cl-granule 
under our conditions, its distribution is not entirely re- 
stricted to this organelle. 
Volume 29 1, number 1 FEBS LETTEWS October 199 1
ally identified GTP-binding protein G,, originally de- [la] Fischer von Mollard, G., Siidhof, T.C. and Jahn, R. (1991) Na- 
scribed in the context of Cat’-independent exocytosis ture 349, 79-81. 
from permeabilized cell systems [17,34]. While non-hy- [13] Bourne, HR. (1988) Cell 53, 669-671. . 
drolyzeable analogues of GTP (e.g. GTPyS) are gener- 
[14] Melancon, P., Glick, B.S., Malhotra, V., Weidman, P.J., Serafini, 
ally inhibitory with respect to membrane fusion pro- 
T., Gleason, ML., Orci, L. and Rothman, J.E. (1987) Ccl1 5 1, 
1053-1062. 
cesses studied in cell-free systems [14,15], under certain 
conditions, GTPyS has been shown to stimulate mem- 
brane fusion [35]. The effector for the GTP-bound form 
of these low molecular mass GTP-binding protein(s) on 
the secretory granule is unknown at the present time. 
However, it may be of significance that phospholipase 
D, which has been indirectly linked with the exocytotic 
secretory process [M--39], has also been recently re- 
ported by us to be under regulation by a GTP-bindiag 
protein of inherently low GTPase activity [SSO]. This is 
a well-known property of GTP-binding proteins belong- 
ing to the ms superfamily [2]. The possibility that phos- 
pholipase D may be a target effector for a secretory 
granule GTP-binding protein would appear, therefore, 
worthy of further investigation. 
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